Pinnacle West Capital (NYSE:PNW) reported its Q2 earnings results on Wednesday, August 3, 2022.
Here's what investors need to know about the announcement.
Keybanc has decided to maintain its Underweight rating of Pinnacle West Capital (NYSE:PNW) and lower its price target from $64.00 to $62.00.
Shares of Pinnacle West Capital are trading down 0.02% over the last 24 hours, at $69.92 per share.
Pinnacle West Capital (NYSE:PNW) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:40 AM.
Here's what investors need to know about the announcement.
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Credit Suisse analyst Nicholas Campanella initiates coverage on Pinnacle West Capital (NYSE:PNW) with a Underperform rating and announces Price Target of $73.